PerformanceRiskValuationProfitabilityCashflowLiquidityESGRevenue & Geographic ExposureForecastFinancial GrowthIncome GrowthCashflow GrowthBalance Sheet Growth
Samsara Inc. (IOT)
33.600.80 (-2.33%)
33.44 - 34.57
31.40 - 61.90
7.61M / 5.95M (Avg.)
-152.73 | -0.22
Steady, sustainable growth is a hallmark of high-quality businesses. Value investors watch these metrics to confirm that the company's fundamental performance aligns with—or outpaces—its current market valuation.
5.95%
Revenue growth above 1.5x MDB's 0.11%. David Dodd would confirm if the firm has a unique advantage driving sales higher.
6.67%
Positive gross profit growth while MDB is negative. John Neff would see a clear operational edge over the competitor.
-93.99%
Both companies show negative EBIT growth. Martin Whitman would consider macro or sector-specific headwinds.
-80.62%
Both companies face negative operating income growth. Martin Whitman would suspect broader market or cost hurdles.
-97.47%
Both companies face declining net income. Martin Whitman would suspect external pressures or flawed business models in the space.
-101.01%
Both companies exhibit negative EPS growth. Martin Whitman would consider sector-wide issues or an unsustainable business environment.
-101.01%
Both face negative diluted EPS growth. Martin Whitman would suspect an industry or cyclical slump with heightened share issuance across the board.
0.72%
Share reduction more than 1.5x MDB's 8.73%. David Dodd would see if the company is taking advantage of undervaluation to retire shares.
0.72%
Diluted share reduction more than 1.5x MDB's 8.73%. David Dodd would validate if the company is aggressively retiring shares or limiting option exercises.
No Data
No Data available this quarter, please select a different quarter.
-2.32%
Negative OCF growth while MDB is at 117.52%. Joel Greenblatt would demand a turnaround plan focusing on real cash generation.
-5.81%
Negative FCF growth while MDB is at 347.61%. Joel Greenblatt would demand improved cost control or more strategic capex discipline.
71.47%
10Y revenue/share CAGR under 50% of MDB's 265.16%. Michael Burry would suspect a lasting competitive disadvantage.
71.47%
5Y revenue/share CAGR under 50% of MDB's 199.59%. Michael Burry would suspect a significant competitive gap or product weakness.
129.82%
3Y revenue/share CAGR above 1.5x MDB's 60.65%. David Dodd would confirm if there's an emerging competitive moat driving recent gains.
158.19%
10Y OCF/share CAGR at 50-75% of MDB's 253.50%. Martin Whitman might fear a structural deficiency in operational efficiency.
158.19%
Below 50% of MDB's 1430.05%. Michael Burry would be alarmed about sustained underperformance in generating free operational cash.
196.37%
3Y OCF/share CAGR under 50% of MDB's 693.32%. Michael Burry would worry about a significant short-term disadvantage in generating operational cash.
76.40%
Similar net income/share CAGR to MDB's 75.02%. Walter Schloss would see parallel tailwinds or expansions for both firms.
76.40%
5Y net income/share CAGR above 1.5x MDB's 50.42%. David Dodd would confirm if the firm’s strategy is more effective in generating mid-term profits.
72.16%
3Y net income/share CAGR 1.25-1.5x MDB's 59.34%. Bruce Berkowitz might see new markets, M&A, or better cost discipline driving the difference.
11.07%
Equity/share CAGR of 11.07% while MDB is zero. Bruce Berkowitz might see a slight advantage that can compound significantly over 10 years.
11.07%
Below 50% of MDB's 3321.57%. Michael Burry sees a substantially weaker mid-term book value expansion strategy in place.
4.69%
Below 50% of MDB's 276.48%. Michael Burry suspects a serious short-term disadvantage in building book value.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
-7.50%
Both reduce receivables yoy. Martin Whitman suspects a shift in the entire niche’s credit approach or softer demand.
-2.65%
Inventory is declining while MDB stands at 0.00%. Joel Greenblatt sees potential cost and margin benefits if sales hold up.
2.44%
Asset growth well under 50% of MDB's 5.66%. Michael Burry sees the competitor as far more aggressive in building resources or capacity.
4.71%
BV/share growth above 1.5x MDB's 0.26%. David Dodd confirms if consistent profit retention or fewer write-downs yield faster equity creation.
2.27%
Debt growth far above MDB's 1.37%. Michael Burry fears the firm is taking on undue leverage vs. the competitor.
13.60%
R&D growth drastically higher vs. MDB's 12.25%. Michael Burry fears near-term margin erosion unless breakthroughs are imminent.
11.38%
SG&A growth well above MDB's 3.05%. Michael Burry sees potential margin erosion unless it translates into higher sales or brand equity.